Education
About Us
Working with TipRanks
Follow Us
Yestar Healthcare Holdings Co Ltd (HK:2393)
:2393
2393 Stock Chart & Stats
HK$0.10
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.10
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.06 - HK$0.20
Previous CloseN/A
Volume710.00K
Average Volume (3M)2.34M
Market Cap
HK$267.91M
Enterprise ValueHK$273.19M
Total Cash (Recent Filing)HK$249.36M
Total Debt (Recent Filing)HK$281.42M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Mar 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding2,331,590,000
10 Day Avg. Volume1,184,000
30 Day Avg. Volume2,342,546
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.29
Price to Sales (P/S)0.06
P/FCF Ratio-5.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Equipment Sales And Service ContractsA mix of equipment sales and recurring service/maintenance contracts creates a durable revenue base. Service contracts provide predictable annuity-like cash flows, smoothing cyclicality of capital sales and supporting long-term customer relationships and aftermarket margins over multiple quarters.
Expansion Into Digital Healthcare And TelemedicineMoving into telemedicine and health IT is a structural positive: digital services scale with lower incremental cost, diversify revenue away from hardware, and align with long-term healthcare digitization trends. This can improve margins and recurring revenue over 2-6 months and beyond.
Positive Shift In Equity During 2024An improvement in equity during 2024 reduces immediate solvency pressure and can lower apparent leverage, improving access to funding and strategic flexibility. Sustained equity recovery would materially reduce refinancing risk and support operational investments.
Bears Say
Historical Negative Equity And Weak Balance SheetPersistent negative equity historically signals cumulative losses and high financial risk. A structurally weak balance sheet limits the company's ability to invest, raises refinancing and covenant risks, and constrains strategic options if profits and cash flow do not sustainably recover.
Inconsistent Operating Cash Flow And Negative FCFInconsistent OCF and negative free cash flow erode financial flexibility and raise dependence on external financing to fund capex, R&D, and working capital. Structurally weak cash generation increases vulnerability to earnings shocks and limits reinvestment capacity.
Deteriorating Gross And EBITDA Margins With Revenue VolatilityFalling gross and EBITDA margins indicate rising cost pressure, pricing weakness, or adverse product mix. Coupled with volatile revenue, this undermines sustainable profitability and operating leverage, making long-term planning and margin recovery more challenging without structural changes.
Yestar Healthcare Holdings Co Ltd News
2393 FAQ
What was Yestar Healthcare Holdings Co Ltd’s price range in the past 12 months?
Yestar Healthcare Holdings Co Ltd lowest stock price was HK$0.06 and its highest was HK$0.20 in the past 12 months.
What is Yestar Healthcare Holdings Co Ltd’s market cap?
Yestar Healthcare Holdings Co Ltd’s market cap is HK$267.91M.
When is Yestar Healthcare Holdings Co Ltd’s upcoming earnings report date?
Yestar Healthcare Holdings Co Ltd’s upcoming earnings report date is Mar 27, 2026 which is in 33 days.
How were Yestar Healthcare Holdings Co Ltd’s earnings last quarter?
Yestar Healthcare Holdings Co Ltd released its earnings results on Aug 29, 2025. The company reported HK$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.003.
Is Yestar Healthcare Holdings Co Ltd overvalued?
According to Wall Street analysts Yestar Healthcare Holdings Co Ltd’s price is currently Overvalued.
Does Yestar Healthcare Holdings Co Ltd pay dividends?
Yestar Healthcare Holdings Co Ltd pays a Annually dividend of HK$0.055 which represents an annual dividend yield of N/A. See more information on Yestar Healthcare Holdings Co Ltd dividends here
What is Yestar Healthcare Holdings Co Ltd’s EPS estimate?
Yestar Healthcare Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yestar Healthcare Holdings Co Ltd have?
Yestar Healthcare Holdings Co Ltd has 2,331,590,000 shares outstanding.
What happened to Yestar Healthcare Holdings Co Ltd’s price movement after its last earnings report?
Yestar Healthcare Holdings Co Ltd reported an EPS of HK$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Yestar Healthcare Holdings Co Ltd?
Currently, no hedge funds are holding shares in HK:2393
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Yestar Healthcare Holdings Co Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
44.31%
12-Months-Change
Fundamentals
Return on Equity
-29.79%
Trailing 12-Months
Asset Growth
-24.49%
Trailing 12-Months
Company Description
Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Company Limited, an investment holding company, engages in the manufacture, distribution, and sale of medical imaging products in Mainland China. It operates through two segments, Imaging Printing Products, and Medical Products and Equipment. The Imaging Printing Products segment manufactures and sells Fujifilm color photographic paper, industrial NDT X-ray films, and PWB films; and trades in imaging equipment. Its products are used in professional and minilabs; and industrial imaging applications. This segment provides NDT X-ray films under the Yes!Star brand. The Medical Products and Equipment segment manufactures and sells medical dry and wet films, and dental films; and sells medical equipment and diagnostic reagents. The company also distributes in vitro diagnostic products. In addition, it engages in the biotechnology development activities; management of supply chain activities; and provision of freight transportation services. The company was formerly known as Yestar International Holdings Company Limited and changed its name to Yestar Healthcare Holdings Company Limited in January 2017. Yestar Healthcare Holdings Company Limited was founded in 1971 and is headquartered in Shanghai, the People's Republic of China.
Technical Analysis
Vincent Medical Holdings Limited
―
Sisram Medical Ltd.
―
China Isotope & Radiation Corp.
―
Suzhou Basecare Medical Corp. Ltd. Class H
―
Austar Lifesciences Ltd.
―